Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.

MLA

Kagaya, Hideaki, et al. “Influence of NAT2 Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients.” Antimicrobial Agents and Chemotherapy, vol. 56, no. 2, Feb. 2012, pp. 825–29. EBSCOhost, https://doi.org/10.1128/AAC.05037-11.

APA

Kagaya, H., Miura, M., Niioka, T., Saito, M., Numakura, K., Habuchi, T., & Satoh, S. (2012). Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients. Antimicrobial Agents and Chemotherapy, 56(2), 825–829. https://doi.org/10.1128/AAC.05037-11

Chicago

Kagaya, Hideaki, Masatomo Miura, Takenori Niioka, Mitsuru Saito, Kazuyuki Numakura, Tomonori Habuchi, and Shigeru Satoh. 2012. “Influence of NAT2 Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients.” Antimicrobial Agents and Chemotherapy 56 (2): 825–29. doi:10.1128/AAC.05037-11.